BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 6, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 28, 2007
View Archived Issues
New Integrity Disease Briefing highlights head and neck cancers
Read More
Preclinical and phase I data on activity of AT-1001 presented
Read More
Satraplatin improves pain and PSA responses in phase III trial
Read More
Vardenafil studies presented at European Association of Urology congress
Read More
LY-2076962, non-morphinan opioid receptor antagonist, evaluated in phase I study
Read More
Celsion files for SPA for ThermoDox
Read More
MEDI-545 begins clinical evaluation in psoriasis
Read More
Novartis signs agreement for branded interferon beta-1b
Read More
New therapeutic agents for thrombotic disorders disclosed in recent patent literature
Read More
Ethics approval for second phase IIa neuropathic pain study of ACV-1
Read More
EvoGenix achieves milestone in GSK collaboration for protein-based therapeutics
Read More
Zanaflu registered as brand name for chitosan gel
Read More
Recent patents report novel analgesic agents
Read More
CHR-2797 begins phase II for AML in elderly patients
Read More
Semafore's PI3K inhibitor studied in phase I for solid tumors
Read More
Arrowhead Research forms new nanomedicine subsidiary
Read More
New agents for treating neurological disorders disclosed in recent patents
Read More
Merck & Co. and Schering-Plough to develop new cholesterol lowering product
Read More
PF-184298 presented as clinical candidate by Pfizer
Read More
Phase III study of vilazodone in depression completes enrollment
Read More
European orphan drug designation for enzastaurin in DLBCL
Read More
orBec cleared for phase II study in prevention of GVHD
Read More
New selective androgen receptor modulator profiled at Merck
Read More
BioLineRx in-licenses new therapeutic candidates
Read More
Positive phase IIa results for DIO-902 in type 2 diabetes
Read More
Cephalon files for European approval of fentanyl effervescent buccal tablet
Read More
Modiodal launched in Japan
Read More
AZ-004 reduces agitation in schizophrenic patients
Read More